Hepatology Research· 2026Q1
Trends in the Proportion of Hepatitis C Virus Antibody‐Positive Patients Who Could be Considered for Direct‐Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real‐World Cohort Study in Japan
- 0citations
- Q1SCImago
- 2026year
Short summary
A nationwide study in Japan found that between 28.4% and 44.4% of Hepatitis C Virus (HCV) antibody-positive patients identified through preoperative ophthalmic surgery testing were eligible for direct-acting antiviral (DAA) therapy from 2019-2023.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hepatology
HepatologyMedicine